MktsMarkets

Black Diamond Therapeutics, Inc.
NASDAQ: BDTXKey statistics
BDTX News
Stories mentioning BDTX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 7,003 | 6,296 | 7,437 | 9,319 | 10,506 | 12,297 | 12,914 | 12,556 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 11,259 | 17,610 | 10,978 | 13,420 | 15,470 | 18,275 | 18,130 | 22,130 |
| Operating Income (Loss) | (11,259) | (17,610) | (10,978) | (13,420) | 54,530 | (18,275) | (18,130) | (22,130) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 1,200 | 1,310 | 1,316 | 1,741 | 1,417 | 1,725 | 2,057 | 1,757 |
| Pretax Income | ||||||||
| Tax Provision | 226.00 | |||||||
| Net Income (Loss) | (9,036) | (15,116) | (8,498) | (10,561) | 56,542 | (15,985) | (15,557) | (19,909) |
| Earnings Per Share (Basic) | (0.16) | (0.27) | (0.15) | (0.19) | 1.00 | (0.29) | (0.28) | (0.36) |
| Earnings Per Share (Diluted) | (0.16) | (0.26) | (0.15) | (0.19) | 0.98 | (0.29) | (0.28) | (0.36) |
| Weighted Average Shares Outstanding (Basic) | 57,233 | 56,868 | 56,929 | 56,803 | 56,664 | 55,028 | 56,508 | 55,155 |
| Weighted Average Shares Outstanding (Diluted) | 57,233 | 57,563 | 56,929 | 56,803 | 57,673 | 55,028 | 56,508 | 55,155 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BDTX
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BDTX. It last traded at $1.43 (Nov 18, 2026, 4:00 PM ET), down 0.7% on the day. That gives Black Diamond Therapeutics a market capitalisation of $82.2M.
Over the past 52 weeks BDTX has traded between $1.40 and $4.48.
For the quarter ended Mar 31, 2026 it reported a net loss of $9.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$9.0M |
| Dec 31, 2025 | — | -$15.1M |
| Sep 30, 2025 | — | -$8.5M |
| Jun 30, 2025 | — | -$10.6M |
From Black Diamond Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…